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ABSTRACT: Peptides have demonstrated unique capabilities to fabricate inorganic nanomaterials of numerous com-
positions through non-covalent binding of the growing surface in solution. In this contribution, we demonstrate that 
these biomolecules can control all facets of Au nanoparticle fabrication, including Au3+ reduction, without the use of 
secondary reagents. In this regard using the AuBP1 peptide, the N-terminal tryptophan residue is responsible for dri-
ving Au3+ reduction to generate Au nanoparticles passivated by the oxidized peptide in solution, where localized 
residue context effects control the reducing strength of the biomolecule. The process was fully monitored by both time-
resolved monitoring of the growth of the localized surface plasmon resonance and transmission electron microscopy. 
Nanoparticle growth occurs by a unique disaggregation of nanoparticle aggregates in solution. Computational model-
ing demonstrated that the oxidized residue of the peptide sequence does not impact the biomolecule’s ability to bind 
the inorganic surface, as compared to the parent peptide, confirming that the biomolecule can be exploited for all steps 
in the nanoparticle fabrication process. Overall, these results expand the utility of peptides for the fabrication of inor-
ganic nanomaterials, more strongly mimicking their use in nature via biomineralization processes. Furthermore, these 
capabilities enhance the simplicity of nanoparticle production and could find rapid use in the generation of complex 
multicomponent materials or nanoparticle assembly.  
Introduction
Bio-inspired approaches for the controlled fabrication 
of  nanostructures  represent  intriguing  and  potentially 
sustainable methods to access materials with enhanced 
properties  for  applications  ranging  from  catalysis  to 
biosensing. DNA,1,2 viruses,3,4  and peptides 5-9  have all 
been used in nanomaterial synthesis resulting in a range 
of particle size, shape, and functionality, indicating that 
the passivant can impact the structure/function relation-
ship.  A common synthetic  approach employed for  the 
preparation of noble metal nanoparticles mixes the bio-
molecules with the metal ions at selected stoichiometric 
ratios.  Upon complexation,  an  exogenous  reductant  is 
added, driving metal ion reduction, leading to zerova-
lent nanoparticle nucleation and growth. As the inorgan-
ic structure grows in solution, the biomolecules bind to 
the  material  through  a  series  of  non-covalent  interac-
tions, impeding growth and controlling particle size. 
While  a  variety  of  biomolecules  have  been  used  to 
generate inorganic nanomaterials, peptides are particu-
larly promising due to their inherent molecular recogni-
tion capabilities that can be exploited to achieve compo-
sitionally selective binding. A significant number of pep-
tide sequences with affinity to specific inorganic surfaces 
have  been  identified  by  biocombinatorial  selection 
methods such as cell-surface and phage display.5,10 From 
this, peptides with affinity for metals, metal oxides, and 
metal sulfides have been identified and used to investi-
gate nanoparticle formation and structure/function rela-
tionships.11-13  Sarikaya  and  coworkers  isolated  the 
AuBP1 sequence (WAGAKRLVLRRE), which has a high 
affinity for Au surfaces14 and rivals the binding of alkane 
thiols on Au.15 The peptide presents five anchor residues 
(W1, A4, R6, R10, and R11), which demonstrate persis-
tent contact with the Au material.14  In general,  AuBP1 
has been used under a variety of conditions to fabricate 
Au nanoparticles; however, the inherent sequence of the 
peptide,  containing  an  important  tryptophan  anchor 
residue,  suggests  additional  functionality  not  typically 
considered for peptides with materials specific binding 
affinity.
Previous studies of individual amino acids and short 
trimer  peptides  have  suggested  that  tryptophan  may 
possess the ability to reduce metal ions to their zerova-
lent  form.  From  this  residue,  inorganic  nanoparticles 
could be generated using the peptide alone without the 
need of an exogenous reductant. Such an effect would 
more  closely  mimic  biomineralization  approaches  ob-
served in biological systems and would enhance the sus-
tainability of  peptide-driven materials approaches.  Tan 
et  al.  have  shown  that  tyrosine  and  tryptophan  free 
amino acids are the most promising to reduce Au3+ to 
Au0.16 Interdigitated peptides were used to enhance the 
binding affinity and engender the biomolecules with the 
ability to reduce Au3+ ions;  however,  the selectivity of 
the peptide for the Au surface and the effects of the oxi-
dized peptide on inorganic affinity remain unexplored. 
What is clear, however, is that the reduction strength of 
the interdigitated peptide is not simply the sum of the 
activity of the individual residues within the sequence. 
More complex peptides such as the AuBP1 could display 
significantly altered reduction and material binding ca-
pabilities compared to the physical mixtures of the inde-
pendent amino acids.
Further  work  by  Si  and Mandal  exploited  synthetic 
trimer peptides with a tryptophan at the C-terminus for 
the fabrication of Au and Ag nanoparticles under basic 
conditions.17 Here it was again suggested that the tryp-
tophan residue  was  responsible  for  particle  reduction, 
potentially by electron transfer where tryptophan is oxi-
dized  to  the  tryptophyl  radical  before  generating  a 
kynurenine residue, as well as other dimerized products. 
While this work suggests that tryptophan possesses the 
ability to reduce Au3+, a complete understanding of how 
this process occurs remains poorly understood. This in-
cludes  the  effects  of  tryptophan  oxidation  on  peptide 
affinity, how the oxidized peptide interacts with the Au 
surface,  how the  peptide  sequence effects  Au3+  reduc-
tion, and how this unique bio-driven reduction process 
alters nanoparticle structures. It is likely that this process 
is substantially different from standard nanoparticle fab-
rication approaches, thus an in depth study focused on 
material growth and biomolecular binding events is re-
quired.
In  this  contribution,  we  have  exploited  the  AuBP1 
peptide  to  examine  the  effects  of  biomolecule-driven 
reduction,  nucleation,  growth,  and  passivation  of  Au 
nanoparticles in a single pot. In this regard, the peptide 
simultaneously  acts  as  both  the  in  situ  reductant  and 
surface passivant,  which has been probed both experi-
mentally and computationally. The peptide-driven Au3+ 
reduction event was monitored by UV-vis analysis of the 
localized surface plasmon resonance (LSPR) band of the 
growing Au nanoparticles. The nanoparticles generated 
in  this  approach were  fully  characterized using  trans-
mission electron microscopy (TEM), including an exam-
ination  of  peptide  concentration  effects  as  well  as  the 
growth of  the particles  throughout the reduction reac-
tion. Additionally, metadynamics simulations were used 
to predict and compare the binding free energies of both 
the kynurenine and tryptophan amino acids at the aque-
ous  Au  interface,  and  Replica  Exchange  with  Solute 
Tempering  (REST)  molecular  dynamics  (MD)  simula-
tions were used to predict the likely structures of AuBP1 
in the tryptophan-oxidized state when adsorbed at the 
interface.  Interestingly,  the  results  suggest  that  under 
acidic conditions the tryptophan residues are oxidized to 
drive  Au  nanoparticle  fabrication  where  kynurenine 
may not be the sole oxidized product. Furthermore, the 
positioning of the tryptophan residue played a signifi-
cant role in the reduction rate; however, it did not sub-
stantially change the final structure of the inorganic ma-
terials.  Such effects are important for use in the single 
pot generation of Au nanoparticles via biomimetic ap-
proaches, which could be exploited for the fabrication of 
intricate structures rivaling the complexity and diversity 
of  biology  for  application  in  optics,  sensing,  catalysis, 
materials assembly, etc.
Experimental section
Materials. HAuCl4 was purchased from Acros Organ-
ics  while  trifluoroacetic  acid  (TFA)  and  tri-isopropyl 
silane (TIS)  were purchased form Alfa  Aesar.  Acetoni-
trile,  methanol,  and  N,N-dimethylformamide  (DMF) 
were purchased form BDH, whereas all FMOC-protected 
amino acids and derivatives, Wang resins, and coupling 
reagents  were  acquired  from  Advanced  Chemtech.  L-
Alanine, L-Lysine, L-Tryptophan, and L-Arginine came 
from  Sigma  Aldrich.  The  remaining  amino  acids,  L-
Glycine  and L-Leucine,  were  purchased from TCI.  All 
reagents were used as received and ultrapure water (18.2 
M!·cm) was employed in all experiments. 
Peptide Synthesis. Solid phase peptide synthesis was 
used following standard protocols on a TETRAS peptide 
synthesizer  (Creosalus).18  Peptides  were  cleaved  from 
the Wang resins  using a  cocktail  of  TIS/H2O/TFA (25 
μL: 25 μL: 950 μL) and purified using reverse-phase high 
performance  liquid  chromatography  (HPLC)  (Waters). 
The purified peptides were confirmed using matrix-as-
sisted laser  desorption/ionization time-of-flight  (MAL-
DI-TOF) mass spectrometry.18 
Peptide-Induced Reduction Reaction.  Each peptide-
driven reduction reaction was  processed at  a  constant 
Au3+ concentration, while the peptide concentration var-
ied such that the peptide:Au3+ ratio ranged from 1-5. A 
description of the reaction for a ratio of 1 is described 
below; however, changes in the volume of peptide solu-
tion and water added were used to change the ratio and 
maintain a constant reaction volume. To a well in a clear 
96-well plate, 20.0 "L of an aqueous 1.0 mM peptide so-
lution was diluted in 160.0 "L of water. To this mixture, 
20.0 "L of 1.0 mM HAuCl4 in water was added and the 
mixture was slightly agitated. The well plate was subse-
quently inserted into the plate reader (Synergy|Mx) to 
monitor the UV-vis absorbance of the material for 1600 
min to ensure that the reaction reached completion.
Characterization. TEM analysis was performed using 
a  JEOL JEM-2010  microscope  operating  at  80  kV.  The 
samples  were  prepared  by  drop-casting  5  "L  of  the 
nanoparticle solution on to a carbon-coated 200 mesh Cu 
grid (EM Sciences) and allowed to dry overnight. Sizing 
of the generated materials was performed on all  grids 
over at least ten images for each grid, including at least 
300 particles at their widest sections.
Modeling.  Two types of molecular simulations were 
utilized. Both cases used the polarizable force-field for 
the Au surface, GolP-CHARMM.19 First, well-tempered 
multiple-walker metadynamics simulations20-22  describ-
ing the adsorption of the Kyn residue, blocked at both 
the  N-  and C-termini,  was  performed  at  the  aqueous 
Au(111) interface using the PLUMED plugin.23 Second, a 
REST simulation24,25 was performed on the AuBP1 kyn 
sequence  adsorbed  at  the  aqueous  Au(111)  interface. 
Based on previously-published analyses, this surface is 
thought to be the dominant facet at the aqueous interface 
of polycrystalline Au.26 Additional information, includ-
ing  full  details  of  the  metadynamics  simulations  and 
REST-MD simulations, and their analyses, can be found 
in  the  Supporting Information:  Computational  Details. 
Recently,  the capabilities  of  the GolP-CHARMM force-
field have demonstrated near-reproduction of the exper-
imentally-determined binding free energy of the AuBP1 
peptide at the aqueous Au interface.26
Results and Discussion
Peptides have been extensively used to fabricate noble 
metal nanoparticles,  especially of Au;1,27  however, they 
require the use of an exogenous reductant to drive re-
duction of Au3+ ions to Au0. It would be ideal for a pep-
tide to control all steps of the fabrication process, includ-
ing the metal ion reduction step. Previous studies have 
suggested that tryptophan could achieve this capability,
17,28-30 but it remains unclear how such a residue, which 
is known to have significantly strong interactions with 
the  metallic  surface,14,31  can  control  this  process  when 
integrated  into  a  peptide  sequence.  Furthermore,  how 
peptide  oxidation affects  Au binding compared to  the 
parent  biomolecule  remains  unstudied.  For  instance, 
context effects, defined as the effects of local residues in 
proximity to tryptophan, could alter the reducing power 
of the residue. As such, an in depth study to elucidate 
these  capabilities  is  required where  both  experimental 
and computational  approaches  must  be  used.  This  in-
cludes  a  fundamental  understanding  of  the  binding 
event at the growing nanoparticle surface of the oxidized 
biomolecule,  as  well  as  identification  of  the  particle 
growth mechanism in solution that is likely to be differ-
ent than standard monolayer protected Au clusters using 
alkanethiols. To study this effect, complementary exper-
imental  and computational  approaches  were  exploited 
using the AuBP1 peptide, which was isolated with Au 
affinity and possesses  an N-terminal  Trp residue.  Fur-
thermore,  this  sequence has  been extensively  used for 
Au nanoparticle fabrication.31,32
The ability of the AuBP1 peptide to reduce Au3+ ions 
was initially studied using UV-vis spectroscopy (Figure 
1a).  In this study, the Au3+ ions are co-mixed with the 
peptides  in  water  at  a  peptide:Au3+  ratio  of  3,  from 
which the solution color gradually changed from faint 
yellow  to  vibrant  pink,  indicative  of  Au  nanoparticle 
formation. During this process, the growth of an LSPR 
band around 540 nm was evident over a reaction time of 
1600 min. The UV- Figure 1. (a) UV-vis analysis of Au3+ 
reduction in  the  presence  of  AuBP1 at  a  peptide:Au3+ 
ratio of 3. (b) Pseudo-first order kinetic analysis of the 
reduction  of  Au3+  in  the  presence  of  AuBP1  at 
peptide:Au3+ ratios of 1 to 5. (c) Calculated k values for 
the reduction of Au3+ in the presence of AuBP1 at pep-
tide:Au3+ ratios of 1 to 5.
vis of the system shows an induction period followed by 
a surprising blue shift from 550 nm to the final position 
at 520 nm. Figure 1b monitors the growth of the LSPR at 
540 nm over time at selected peptide:Au3+ ratios ranging 
from 1-5. In these studies, the peptide concentration in-
creased while the Au3+ concentration in the reaction re-
mained constant.  In  this  analysis,  the  rate  of  plasmon 
growth clearly increases as the concentration of the pep-
tide also increases. From these data, the pseudo first-or-
der rate  constants  (k)  were calculated by standard ap-
proaches  (Figure  1c).33,34  Briefly,  the  natural  log of  the 
absorbance at 540 nm, divided by the initial absorbance 
at  this  wavelength,  was plotted as  a  function of  time. 
The data was subsequently fit with a linear best fit line, 
from which the slope of this line represents the pseudo 
first  order  rate  constant.  Interestingly,  when  the 
AuBP1:Au3+ ratio was set at 1, a k value of (1.87 ± 0.06) × 
10−3  min-1  was determined, which increased in magni-
tude as the amount of peptide in the reaction increased 
to a ratio of 5, resulting in a rate constant of (6.17 ± 0.49) 
× 10−3 min-1. Such results strongly indicate that the pep-
tide itself  is  capable of  driving the chemical  reduction 
process where no bulk precipitate was noted even after 
1600 min of reaction. The lack of precipitation suggests 
that  the peptide that  is  oxidized during the metal  ion 
reduction  process  retains  sufficient  affinity  for  the  Au 
surface to stabilize the growing nanoparticles dispersed 
in solution.
After  completion  of  the  peptide-driven  reduction 
process, the Au particles generated at each AuBP1:Au3+ 
ratio
Figure 2.  TEM images (left)  and particle  size distribution 
histograms  (right)  of  AuBP1  driven  Au3+  reduction  after 
1000 min at peptide:Au3+ ratios of (a) 1, (b) 2, (c) 3, (d) 4, 
and (e) 5.
were imaged using TEM (Figure 2).  In general,  spher-
oidal-shaped metallic  materials  were fabricated,  which 
were stabilized by the peptide in the reaction mixture. 
Note that  when the reaction was processed in the ab-
sence of peptide, no Au3+ reduction was observed, thus 
no  TEM  analysis  of  the  peptide-free  control  could  be 
studied. When the materials prepared at a peptide:Au3+ 
ratio of 1 were analyzed (Figure 2a),  Au nanoparticles 
with  an  average  diameter  of  20.2  ±  9.2  nm  were  ob-
served.  As  the  peptide  concentration  increased  in  the 
reaction  (Figures  2b-d),  a  minor  shift  towards  smaller 
material sizes was noted where an average diameter of 
17.0 ± 5.4 nm was observed for the materials prepared at 
a ratio of 5 (Figure 2e). While the average size showed 
only a minor change, the distribution in the nanoparticle 
sizes observed in each sample notably diminished when 
higher concentrations of peptides were used in the reac-
tion. Such a distribution effect was to be anticipated as 
additional peptide was present in the reaction mixture to 
ensure efficient passivation of the growing Au nanopar-
ticle surface at higher peptide:Au3+ ratios. 
While it is evident that the AuBP1 peptide is driving 
the reduction of Au3+ ions in solution, the mechanism of 
such a process remains unclear. Interestingly, while Au 
nanoparticles  of  ~10-20  nm  are  generated,  the  UV-vis 
studies suggest a unique process is occurring to result in 
these  structures.  Here,  a  clear  blue  shift  in  the  LSPR 
band of the growing materials is evident from 550 nm to 
520 nm throughout the reaction. This would suggest that 
changes in particle  size from larger  to smaller  are ob-
served  during  the  Au  nanoparticle  formation  process. 
Typically  Au nanoparticles  nucleate  at  individual  sites 
and then grow via Au atom adsorption onto the nuclei.35 
Once the particle surface is passivated with the ligand in 
solution, the reaction is quenched to maintain the parti-
cle size, thus the particles grow from the atomic scale to 
the larger nanoscale regime. In this approach, a red shift-
ing  LSPR peak  would  be  anticipated  as  the  materials 
grow from smaller to larger. 
To  monitor  the  growth  mechanism  of  the  peptide-
based reduction process, TEM imaging of the materials 
throughout the reaction at a peptide:Au3+ ratio of 3 was 
processed (Figure 3). For this, an aliquot of the reaction 
was removed from the solution, rapidly added to TEM 
grid sur  face, and then allowed to dry in a desiccator. 
Once dried, the materials deposited on the grid surface 
were  imaged and analyzed for  changes  in  particle  di-
mensions as a function of reaction progression. Figure 3a 
presents the image of the materials after 60 min of reduc-
tion, while Figure S4 in the Supporting Information pro-
vides an additional image at lower magnification. In this 
sample,  large,  dendritic-like  inorganic  materials  were 
observed,  where  it  appeared  as  if  individual  Au 
nanoparticles were arranged to generate the large struc-
ture. Sizing analysis of the materials demonstrated that 
the average width of the global structure was 80.2 ± 37.2 
nm. This analysis was completed across the entire width 
of the structure from the largest dimension. Unfortunate-
ly,  measurements  of  the individual  components  of  the 
aggregated structure could not  be assessed due to the 
significant  overlap between the  different  particle  com-
ponents.
When the reaction materials generated after 248 min of 
reduction  were  studied,  a  clear  shift  in  material  mor-
phology was noted (Figure  3b).  For  this  time point,  a 
polydisperse set of materials was observed, where both 
individual Au nanoparticles and nanoparticle aggregates 
were noted in this  sample.  The average material  sizes 
were calculated, where a shift to a smaller dimension of 
29.4  ±  10.3  nm was seen.  Note  that  this  measurement 
incorporates both material populations into a single his-
togram  for  the  individual  particles  and  the  width  of 
nanoparticle aggregates, which gives rise to the signifi-
cantly  broad particle  Figure  3.  TEM images  (left)  and 
particle  size  distribution  histograms  (right)  of  AuBP1-
driven Au3+ reduction at a peptide:Au3+ ratio of 3 after 
(a) 60, (b) 248, (c) 436, (d) 624, (e) 812, and (f) 1000 min of 
reduction. 
distribution analysis.  Due to difficulties in distinguish-
ing  between  individual  particles  and  smaller  particle 
aggregates, bifurcating the measurement into two popu-
lations  was  not  possible.  After  436  min  of  reduction 
(Figure 3c), analysis of the materials demonstrated only 
individual Au nanoparticles on the TEM grid, where no 
nanoparticle aggregates were observed. For these mate-
rials,  a  particle  diameter  of  13.9  ±  8.2  nm was  noted, 
where the average particle size remained roughly con-
stant after longer times of reduction (Figure 3d-f). From 
this  time-based  analysis,  it  is  evident  that  large,  Au 
nanoparticle  aggregated  structures  are  rapidly  formed 
by  peptide-driven  reduction  and  eventually  disaggre-
gate throughout the reaction process. This gives rise to 
the observed blue shifts in the UV-vis spectrum of the 
material LSPR. Such a disaggregation process is unique 
compared to standard nanoparticle growth mechanisms. 
While  a  distinctive  Au  nanoparticle  growth  mecha-
nism appears to be evident,  the basis of  the reductant 
capability  of  the  AuBP1  remains  poorly  understood. 
Previous studies  have indicated that  individual  amino 
acids can drive the reduction of metal ions to the zerova-
lent state;10,17,29,36 however, varying degrees of reduction 
strength are  possible.  In  general,  tryptophan has  been 
demonstrated to have significant reducing capabilities to 
generate Au0 from Au3+ ions. 10,17,29,36 In basic media, this 
process occurs through deprotonation of the tryptophan 
by the base,  where the amino acid is then oxidized to 
generate kynurenine as well as other oxidative products; 
however,  the  effects  of  the  amino  acid  sequence  and 
composition of peptide remains poorly understood. Pep-
tide sequence effects are known to alter the global prop-
erties of the biomolecules,16 thus they are likely to shift 
the reducing capabilities of the tryptophan residue. 
To probe peptide-based metal  ion reducing capabili-
ties,  two control  peptides  with  known affinity  for  Au 
were  studied  for  Au3+  reduction:  AuBP2  (WALRRSIR-
RQSY)  and  Pd4  (TSNAVHPTLRHL).14  These  two  se-
quences were selected as the AuBP2 peptide possesses a 
tryptophan residue, while the Pd4 does not, thus serving 
as  ideal  positive  and negative  controls  of  tryptophan-
driven Au3+ reduction. Using these two peptides, antici-
pated  degrees  of  Au3+  reduction  capabilities  were  ob-
served, as shown in Figure 4. The k values of the AuBP1 
driven  system  are  shown  for  comparison  (Figure  4a). 
Here, the AuBP2 sequence was able to drive the reduc-
tion process at the selected peptide:Au3+ ratios with rate 
constants ranging from (1.97 ± 0.06) × 10−3 min-1 to (5.77 
± 0.12) × 10−3 min-1 at ratios of 1 and 5, respectively. Such 
values  are  similar  to  those  observed with  the  initially 
studied AuBP1 peptide. Note that the both the AuBP1 
and  AuBP2  peptides  have  N-terminal  tryptophan 
residues followed by an alanine. As such, the local envi-
ronment  for  the  tryptophan  is  similar.  TEM  analysis 
(Figure 4b) of the Au nanoparticles generated via AuBP2 
reduction  at  a  peptide:Au3+  ratio  of  3  after  1000  min 
demonstrated polydisperse particles of sizes comparable 
to those generated using the AuBP1 (6.3 ± 4.1 nm) When 
using the Pd4 peptide as the reductant, no Au nanopar-
ticle formation was observed due to a lack of LSPR for-
mation over  the time frame of  the reaction,  consistent 
with the lack of reduction capabilities, regardless of the 
Pd4:Au3+  ratio  employed.  This  strongly  supports  the 
effect of the tryptophan being responsible for the metal 
ion reduction process. 
Figure  4.  Au3+  reduction  capability  comparison of  the 
AuBP2 and Pd4 peptides to AuBP1. Part (a)  compares 
the  first  order  rate  constants  as  a  function  of  the 
peptide:Au3+ ratio, while part (b) presents a TEM image 
of Au nanoparticles made by AuBP2 after 1000 min of 
reduction using an AuBP2:Au3+ ratio of 3.
While  the positive (AuBP2)  and negative (Pd4)  con-
trols confirmed the activity of the tryptophan residue for 
Au3+  reduction,  they  did  not  probe  the  effects  of  the 
residue context  within the peptide sequence.  To probe 
these effects, a series of AuBP1 peptides with modified 
sequences or individual amino acids were probed (Fig-
ure 5). For instance, when physical mixtures of the indi-
vidual amino acids of the AuBP1 peptide were dissolved 
with Au3+ ions at the concentrations that they would be 
at using the peptides, negligible metal ion reduction was 
noted (indicated 
Figure  5.  (a)  UV-vis  analysis  of  Au3+  reduction in  the 
presence  of  the  physical  mixture  of  individual  amino 
acids of the AuBP1 at a peptide:Au3+ ratio of 3. (b) UV-
vis analysis of Au3+ reduction in the presence AuBP1 R 
at a peptide:Au3+ ratio of 3. (c) UV-vis analysis of Au3+ 
reduction  in  the  presence  AuBP1  A at  a  peptide:Au3+ 
ratio of 3. (d) Comparison of the calculated k values for 
the reduction of Au3+ in the presence of AuBP1, AuBP1 
PM, AuBP1 R, and AuBP1 A at peptide:Au3+ ratios of 1 
to 5.
as AuBP1 PM in Figure 5a and d). From this, the maxi-
mum rate constant of Au3+ reduction was (0.3 ± 0.2) × 
10−3 min−1, which is six times lower than values obtained 
for the AuBP1 peptide. This indicates that integrating the 
tryptophan residue into a peptide sequence is critically 
important in controlling the overall  reduction capabili-
ties. Furthermore, a new peptide sequence was generat-
ed  where  the  tryptophan  residue  of  the  AuBP1  was 
swapped for an alanine (termed AuBP1 A – Figure 5c). 
This modification resulted in complete loss of peptide-
driven Au3+ reduction, further confirming the reactivity 
of  the  tryptophan.  Finally,  a  second  modified  AuBP1 
peptide was synthesized where the  residue order  was 
randomized to generate a new sequence (termed AuBP1 
R – VRGERLKAWLAR; Figure 5b). Note that the trypto-
phan residue is no longer at one of the peptide termini, 
but buried within the sequence. When using this peptide 
to reduce Au3+, a substantial increase in reactivity was 
observed, where the k values at the selected ratios were 
generally greater than those for the parent AuBP1 pep-
tide. For instance, at a peptide:Au3+ ratio of 5, the AuBP1 
driven reduction process demonstrated a k value of (6.17 
± 0.49) × 10−3 min-1; however, using the AuBP1 R system, 
a rate constant of (8.1 ± 1.08) × 10−3 min-1 was calculated. 
Based upon these results, it is clear that the tryptophan 
residue  is  responsible  for  the  reduction  of  Au3+  ions, 
while the entire peptide mediates the growth, passiva-
tion,  and stabilization of  Au nanoparticles  in solution. 
Furthermore, the reducing capabilities appear to be con-
text specific, where the neighboring residues of the tryp-
tophan,  as  well  as  potentially  the  entire  peptide  se-
quence,  plays  a  role  in  modulating  the  reducing 
strength. In the mechanism proposed by Si and Mandal, 
under  basic  conditions,  tryptophan  is  oxidized  to  the 
tryptophyl radical in the presence of Au3+ ions before it 
reacts  to  form  ditryptophan,  N-formyl-kynurenine, 
kynurenine,  and other cross-linked products.  17,30  Note 
that  the  present  system is  being  studied  under  acidic 
conditions (pH 3.49). To probe the effects of an oxidized 
product on the observed peptide reduction and binding 
process,  kynurenine,  a significant oxidation product of 
tryptophan, was substituted into the AuBP1 peptide to 
replace tryptophan. If kynurenine was the final product, 
then  the  new  oxidized  N-terminus  could  significantly 
alter the binding affinity of the oxidized peptide to the 
Au surface,  as  well  as  the  reduction  capability  of  the 
peptide.
AuBP1  kyn  (kynAGAKRLVLRRE)  was  synthesized, 
substituting  tryptophan  with  the  oxidation  product 
kynurenine,  to  understand  the  effects  of  the  oxidized 
biomolecule on the reduction of Au3+ and its binding to 
the aqueous Au0 surface. To compare the binding affinity 
of  AuBP1 to AuBP1 kyn,  Quartz Crystal  Microbalance 
(QCM) studies were performed on Au sensors.  In this 
analysis,  increasing concentrations of AuBP1 kyn were 
flowed over Au sensors and the frequency change of the 
sensors were measured as the peptide adsorbed to the 
metallic surface. This adsorption was modeled using a 
Langmuir fit to extrapolate ∆G for the binding of AuBP1 
kyn  using  previously  described  approaches.14  The  ∆G 
determined for AuBP1 kyn binding was -37.8 ± 5.2 kJ/
mol, which is nearly identical for the value previously 
quantitated for AuBP1 on Au (-37.6 ± 0.9 kJ/mol).14 This 
indicates  that  the binding affinity of  the oxidized bio-
molecule  shows  no  significant  difference  compared  to 
the binding affinity of the initial peptide. 
Computational modeling further corroborated this find-
ing. First, metadynamics MD simulations were used to 
predict the binding free energy of independent kynure-
nine (i.e.  in amino acid form) at the aqueous Au inter-
face. By integrating the change in free energy (see Com-
putational  Details  in  the Supporting Information)  as  a 
function of distance from the surface (see Figure S15 in 
the Supporting Information for both Trp and Kyn), the 
free energy of adsorption was obtained and calculated to 
be -20.3 ± 0.8 kJ mol-1 for Kyn, while the corresponding 
value for Trp was -19.7 ± 2.4 kJ mol-1. These data indicate 
that the adsorption free energy for both residues can be 
considered equivalent (within error). Thus Kyn, like Trp 
can serve as a very strong anchor residue at the aqueous 
Au interface.
Figure 6. (a) Summary of the contact residue data for the 
AuBP1 kyn sequence adsorbed at the Au aqueous inter-
face. For each residue, we give the percentage of the en-
tire REST-MD reference trajectory (%) that each residue 
is determined to be in contact with the surface. (b) Cor-
responding  contact  data  for  the  parent  AuBP1  se-
quence31, are shown for comparison. (c) Representative 
structure  (plan  view)  of  AuBP1  kyn  adsorbed  at  the 
aqueous  Au  (111)  interface.  The  Au(111)  surface  is  a 
widely accepted model for the Au substrate (see meth-
ods). Water molecules not shown for clarity. 
To investigate how the peptide environment affected 
the  surface  adsorption  of  the  Kyn  residue,  REST-MD 
simulations were performed on the AuBP1 kyn sequence 
adsorbed at the aqueous Au interface. From these simu-
lations, the degree of surface contact was calculated for 
each residue. These findings were compared to the find-
ings for the parent AuBP1 peptide,14 as summarized in 
Figure 6a (see Table S1 in the Supporting Information for 
numerical values). Overall, the number and location of 
key anchor residues in AuBP1 appear to have been pre-
served in AuBP1 kyn. This means the general binding 
mode of AuBP1 kyn is predicted to be very similar with 
that  of  AuBP1,  where a representative adsorbed struc-
ture of AuBP1 kyn is illustrated in Figure 6b.
Once the binding analysis of the AuBP1 kyn peptide 
was  more  fully  understood,  its  ability  to  reduce  Au3+ 
ions was examined (Figure 7a). Using identical methods 
as 
Figure 7. (a) UV-vis analysis of Au3+ reduction in the pres-
ence of AuBP1 kyn at  a peptide:Au3+ ratio of  3.  (b)  TEM 
analysis  of  particles  made  with  AuBP1  kyn  at  a 
peptide:Au3+ ratio of 3. (c) pseudo-first order kinetic analy-
sis of the reduction of Au3+ in the presence of AuBP1 kyn at 
peptide: Au3+ ratios of 1-5. (d) A comparative bar chart of 
the calculated k values for the reduction of Au3+ in the pres-
ence of AuBP1 and AuBP1 kyn. 
employed with the parent AuBP1, increasing amounts of 
AuBP1 kyn were exposed to a constant amount of Au3+ 
where substantially diminished k values were noted for 
the reduction reaction. As shown in Figure 7c and d, the 
reduction rate of Au3+ to Au0 for the kynurenine-baring 
peptide at a peptide:Au3+ ratio of 1 was (1.37 ± 0.11) × 
10−3 min-1, which was reduced compared to the AuBP1 
under the same conditions. Note that the pH of the two 
system were very similar:  3.49 for AuBP1 and 3.65 for 
AuBP1 kyn. While greater k  values were noted for the 
AuBP1 parent  system as  the peptide concentration in-
creased, only minor k  value changes were noted when 
the AuBP1 kyn peptide concentration was increased. As 
such,  the  rate  constants  for  the  kynurenine-containing 
molecules were substantially lower as compared to the 
parent. Interestingly, TEM analysis (Figure 7b) indicated 
that the particles generated using the AuBP1 kyn pep-
tide were smaller with an average size of 8.5 ±  4.1 nm 
using a peptide:Au3+ ratio of 5.
    These results using the AuBP1 kyn peptide demon-
strate that the oxidation of the peptide presents minimal 
changes on the affinity of the biomolecule to the target 
surface; however, in the presence of AuBP1 kyn, contin-
ued oxidation of the kyn residue persists for Au3+ reduc-
tion. This suggests that while kyn may be an intermedi-
ate  product  during  AuBP1  driven  Au3+  reduction  via 
tryptophan oxidation, this may not be the final product 
under  acidic  conditions.  Previous  work  demonstrated 
reactivity  under  basic  conditions,  where  the  current 
acidic conditions are likely to alter reactivity pathways 
where  additional  solution  conditions  may  alter/affect 
the overall reactivity. Due to the small amount of peptide 
in the reaction mixture,  mass spec analysis of  the bio-
molecule after Au nanoparticle formation could not be 
processed;  however,  additional  studies  are  presently 
underway to further understand this unique bio-based 
reduction capability. 
Conclusions
In conclusion, these results demonstrate that biomole-
cules are highly unique with the ability to fabricate Au 
nanoparticles from Au3+ reduction to surface passivation 
and stabilization without the use of additional reagents. 
Such capabilities are important for sustainable nanopar-
ticle production and could be important for specific ap-
plications where deposition of nanoparticles at specific 
locations is required. The reduction activity was deter-
mined to  arise  from a  Trp residue  within  the  peptide 
sequence,  where  the  reactivity  is  sensitive  to  the  local 
environment  surrounding  the  residue.  This  effect  was 
confirmed using synthetic mutation studies,  as well  as 
positive  and  negative  control  sequences.  Interestingly, 
nanoparticle growth by this mechanism follows a unique 
disaggregation process  from large material  aggregates, 
as observed by TEM and a blue shifting LSPR. Further-
more, as confirmed by computational modeling, oxida-
tion of the Trp residue in the biomolecule imparts negli-
gible changes on the peptide Au affinity or binding pat-
tern,  thus  indicating  that  the  Au3+  reduction  process 
does not  diminish the ligand’s  ability  to  passivate  the 
metallic surface. Overall, such multifunctional capabili-
ties  from a  single  peptide  ligand are  highly  attractive 
and  simplify  material  fabrication  schemes.  Additional 
effects  of  solution  conditions  and  the  overall  peptide 
sequence are likely to further modify the Au nanoparti-
cle reduction process,  all  of which are currently under 
study in our laboratories. 
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